Trials / Conditions / Esophageal Squamous Carcinoma
Esophageal Squamous Carcinoma
4 registered clinical trials studyying Esophageal Squamous Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC NCT07490002 | Changhai Hospital | Phase 2 |
| Unknown | DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC NCT06055153 | Changhai Hospital | Phase 1 / Phase 2 |
| Unknown | JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard Ther NCT05164848 | Peking University | Phase 1 |
| Unknown | Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma NCT01752205 | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Phase 3 |